Home » Medical Devices » Cardiovascular Devices Market

Cardiovascular Devices Market

Cardiovascular Devices Market By Product (Diagnostic & Monitoring Devices, Surgical Devices); By End User (Hospitals & Clinics, Diagnostic Laboratories, Ambulatory Surgical Centers, Others); By Diagnostic & Monitoring Devices Type (ECG, Implantable Cardiac Monitors, Holter Monitors, Mobile Cardiac Telemetry, MRI, Others); By Surgical Devices Type (Cardiac Resynchronization Therapy (CRT), Implantable Cardioverter Defibrillators (ICDs), Pacemakers, Coronary Stents, Catheters) – Growth, Share, Opportunities & Competitive Analysis, 2024 – 2032

Summary
Table Of Content

REPORT ATTRIBUTE	DETAILS
Historical Period	2020-2023
Base Year	2024
Forecast Period	2025-2032
Cardiovascular Devices Market Size 2024	USD 72,115.60 million
Cardiovascular Devices Market , CGR	7.1%
Cardiovascular Devices Market Size 2032	USD 133,700.94 million

Market Overview

The Global Cardiovascular Devices Market is projected to grow from USD 72,115.60 million in 2024 to an estimated USD 133,700.94 million by 2032, with a compound annual growth rate (CAGR) of 7.1% from 2025 to 2032. The increasing prevalence of cardiovascular diseases, along with advancements in medical technology, is driving significant growth in the market.

Key drivers of the cardiovascular devices market include the growing incidence of heart-related diseases such as coronary artery diseases, heart failure, and arrhythmia. Additionally, increasing awareness about heart health and advancements in diagnostic technologies are encouraging early detection and treatment. Trends such as the adoption of remote monitoring systems and wearable cardiovascular devices are also fueling the demand for innovative cardiovascular solutions. Technological advancements, including the development of next-generation stents, pacemakers, and defibrillators, continue to shape the future of the market.

Geographically, North America dominates the cardiovascular devices market, contributing to a significant share due to its advanced healthcare infrastructure and high prevalence of cardiovascular diseases. The Asia Pacific region, however, is expected to witness the highest growth rate due to the increasing healthcare investments, improving medical infrastructure, and a rising patient pool in countries like India and China. Key players in the market include Medtronic, Abbott Laboratories, Boston Scientific, and Philips Healthcare, who continue to lead in technological innovations and product offerings.

Access crucial information at unmatched prices!

Request your sample report today & start making informed decisions powered by Credence Research!

Download Sample

Market Insights

The global cardiovascular devices market is projected to grow from USD 72,115.60 million in 2024 to USD 133,700.94 million by 2032, with a CAGR of 7.1% from 2025 to 2032, driven by increasing cardiovascular diseases and advancements in medical technology.
Key drivers include the rising prevalence of heart-related diseases, an aging population, and the growing demand for minimally invasive procedures and innovative cardiovascular devices like pacemakers and stents.
Innovations such as next-generation diagnostic tools, AI-powered devices, and wearable health devices are fueling growth by enabling early detection, remote monitoring, and better patient outcomes.
High costs of advanced cardiovascular devices and regulatory hurdles for new product approvals remain significant challenges to market growth, particularly in emerging economies with limited healthcare access.
North America holds the largest market share due to its well-established healthcare infrastructure, high healthcare spending, and the high incidence of cardiovascular diseases.
The Asia Pacific region is expected to experience the fastest growth, driven by increasing healthcare investments, improved medical infrastructure, and a large patient pool in countries like China and India.
Leading players such as Medtronic, Abbott Laboratories, Boston Scientific, and Philips Healthcare are at the forefront of technological innovation, shaping the competitive dynamics of the cardiovascular devices market.

Report Scope

This report segments the Global Cardiovascular Devices Market as follows:

Market Drivers

Rising Prevalence of Cardiovascular Diseases

The increasing incidence of cardiovascular diseases (CVDs) is a significant driver for the growth of the cardiovascular devices market. Cardiovascular diseases, including coronary artery diseases, arrhythmias, and heart failure, are among the leading causes of morbidity and mortality worldwide. According to the World Health Organization (WHO), CVDs are responsible for nearly 32% of global deaths. For instance, leading medical device companies have introduced advanced cardiovascular solutions to address this growing burden. In 2024, Medtronic launched AI-powered enhancements for its Reveal Linq ICM devices, improving early detection of heart conditions. Additionally, major healthcare providers have expanded their cardiovascular care units, with several hospitals adding new catheterization labs and cardiac surgery centers to meet increasing patient needs. As the number of individuals diagnosed with heart disease rises, the demand for diagnostic and therapeutic cardiovascular devices—such as pacemakers, stents, and defibrillators—also increases. This surge in disease incidence not only boosts the need for more cardiovascular devices but also encourages significant investments in research and development to improve the treatment options available to patients.

Technological Advancements in Cardiovascular Devices

Technological advancements play a pivotal role in driving the growth of the global cardiovascular devices market. Innovations in device design, materials, and functionality have led to the development of more effective, minimally invasive, and patient-friendly devices. For instance, the introduction of bioresorbable stents, which dissolve in the body over time, has significantly reduced complications associated with traditional metallic stents. Furthermore, the rise of implantable devices such as smart pacemakers and defibrillators equipped with remote monitoring capabilities has revolutionized patient care. These advancements enable early detection, better management of cardiovascular conditions, and a reduction in hospital visits, leading to enhanced patient outcomes. Technological innovations also extend to cardiovascular imaging, diagnostic equipment, and surgical instruments, all of which are essential to the accurate diagnosis and treatment of heart diseases. The ongoing focus on improving device precision, durability, and ease of use continues to propel the market forward.

Growing Focus on Preventive Healthcare and Early Diagnosis

Increasing awareness of the importance of preventive healthcare and early diagnosis of cardiovascular diseases is contributing significantly to market growth. There has been a noticeable shift towards prevention rather than treatment in the healthcare industry, as early intervention has been proven to improve patient outcomes and reduce healthcare costs. The availability of non-invasive cardiovascular diagnostic devices, such as echocardiograms, ECGs, and wearable heart rate monitors, allows for regular monitoring and early detection of potential heart conditions. This shift has fostered the use of cardiovascular devices not only in hospitals but also in outpatient settings, home care, and wellness programs. Governments and private organizations are also promoting awareness campaigns that emphasize lifestyle changes, including healthier diets and increased physical activity, which have further fueled the demand for devices that help monitor heart health. Preventive measures, such as routine screenings and patient monitoring systems, are playing an increasingly important role in reducing the burden of cardiovascular diseases globally.

Aging Population and Improved Access to Healthcare

The global aging population is one of the most significant contributors to the increasing demand for cardiovascular devices. As life expectancy increases, especially in developed economies, the proportion of elderly individuals continues to rise. This demographic shift is associated with a higher prevalence of cardiovascular diseases, as aging is a key risk factor for heart conditions. For example, the risk of heart failure and coronary artery disease significantly increases after the age of 65. In response to the growing number of elderly patients, healthcare providers are focusing on expanding their cardiovascular offerings to cater to this population. Additionally, improved access to healthcare, particularly in emerging markets, has made it easier for patients to receive cardiovascular treatment and intervention. As healthcare infrastructure improves in developing countries, there is an increasing adoption of advanced cardiovascular devices for diagnosis, treatment, and monitoring. Government initiatives to support healthcare access, alongside the expansion of private healthcare networks, have also played a key role in making cardiovascular devices more widely available.

Market Trends

Minimally Invasive Procedures and Device Innovation

The shift towards minimally invasive procedures is one of the dominant trends in the global cardiovascular devices market. Patients and healthcare providers are increasingly preferring treatments that reduce the need for large incisions, leading to shorter recovery times, reduced risk of infection, and lower healthcare costs. For instance, minimally invasive cardiac surgery techniques such as robotic-assisted coronary artery bypass grafting (CABG) and transcatheter aortic valve replacement (TAVR) have been widely adopted in leading cardiovascular centers worldwide. Studies indicate that robotic-assisted cardiac procedures have demonstrated high success rates and lower complication risks compared to traditional open-heart surgeries. Innovations in device design, such as catheter-based interventions, robotic-assisted surgeries, and bioresorbable stents, are enabling these procedures to become more effective and accessible. These advancements allow for greater precision in device placement, minimizing patient trauma. As a result, patients are experiencing faster recoveries and fewer complications. Additionally, the growing focus on patient comfort and device compatibility has led to the development of smaller, more durable cardiovascular devices, further promoting the shift towards minimally invasive treatments. This trend is particularly prominent in procedures like CABG and percutaneous coronary interventions (PCI), both of which benefit from these innovations.

Rise of Wearable and Remote Monitoring Devices

The increasing popularity of wearable health devices is transforming the cardiovascular care landscape. Wearable devices such as smartwatches, ECG monitors, and blood pressure cuffs are enabling real-time heart monitoring, offering patients the ability to track their cardiovascular health from the comfort of their homes. For instance, AI-powered wearable cardiac monitors are being integrated into healthcare systems to enhance early detection of cardiovascular diseases. Research highlights that AI-driven cardiac devices can analyze fluctuations in heart rhythms and optimize therapy delivery based on real-time data. These devices allow for early detection of potential cardiovascular issues, facilitating proactive treatment and management. Remote monitoring, often coupled with telemedicine, is becoming an essential tool in managing chronic cardiovascular conditions, such as arrhythmias and heart failure. This trend not only empowers patients to take control of their health but also reduces the burden on healthcare facilities, as healthcare providers can monitor patients remotely and intervene when necessary. As technology advances, wearable cardiovascular devices are becoming more accurate, more comfortable, and more integrated with other healthcare systems, further enhancing their appeal.

Integration of Artificial Intelligence and Machine Learning

The integration of artificial intelligence (AI) and machine learning (ML) into cardiovascular devices and diagnostics is one of the most significant trends shaping the market. AI-powered algorithms are now being used to assist in diagnosing cardiovascular conditions more accurately and quickly. For example, AI tools can analyze ECG readings and imaging results to detect abnormalities like arrhythmias or heart disease with high precision. These technologies are also improving the efficiency of cardiovascular devices, enabling them to adapt to real-time patient data and provide personalized treatment recommendations. Machine learning, in particular, is playing a pivotal role in predictive analytics, helping healthcare providers anticipate adverse cardiovascular events before they occur. This trend is expected to reduce the risk of complications, improve outcomes, and lower treatment costs. The ongoing development of AI and ML applications in cardiovascular devices continues to open new frontiers in patient care and device functionality.

Growing Focus on Customized and Patient-Centric Solutions

There is a growing trend towards the development of customized and patient-centric cardiovascular devices, tailored to meet the specific needs of individual patients. Advances in 3D printing and personalized medicine are enabling the creation of devices that are better suited to a patient’s unique anatomical features and health requirements. For instance, customized stents, heart valves, and pacemakers are now being designed to fit the patient’s precise biological makeup, improving both device efficacy and patient comfort. This shift towards personalization is also driven by the desire to provide more targeted treatments for conditions like congenital heart defects, where standard devices may not be as effective. Additionally, patient-centric solutions are extending to the design and usability of devices, with features such as intuitive interfaces, remote monitoring capabilities, and enhanced portability. The demand for these personalized solutions is expected to continue to rise, as they contribute to better patient outcomes, greater satisfaction, and overall improvements in cardiovascular care.

Market Challenges

Regulatory and Compliance Challenges

The global cardiovascular devices market faces significant regulatory hurdles, which can impede market growth and delay the introduction of new technologies. Each country has its own set of stringent regulations and standards for medical devices, making it challenging for manufacturers to navigate the complex approval processes. Regulatory bodies such as the U.S. Food and Drug Administration (FDA), the European Medicines Agency (EMA), and others set high standards for safety, efficacy, and clinical performance before devices can be marketed. While these regulations are essential for ensuring patient safety, they also lead to lengthy approval timelines, increased costs, and the risk of non-compliance. Furthermore, regulatory changes, such as modifications in standards for clinical trials or product certifications, can introduce uncertainty in the market, requiring companies to continuously adapt their strategies. For global manufacturers, complying with varying regulatory requirements across regions can be a resource-intensive process, and any delays in approvals or changes in regulations can impact product launch schedules and profitability. The ongoing need for compliance and regulatory updates poses a challenge to the cardiovascular devices market, particularly for smaller companies that may struggle to meet the demands of international markets.

Market Opportunities

Expansion in Emerging Markets

One of the primary challenges facing the global cardiovascular devices market is the high cost associated with advanced technologies and devices. Devices such as stents, pacemakers, defibrillators, and diagnostic equipment often come with a substantial price tag, which can limit their accessibility, especially in low- and middle-income countries. The cost is further exacerbated by the expense of research and development (R&D) required to innovate and manufacture these devices. While high-cost devices offer advanced features and improved outcomes, they may not be affordable for a significant portion of the global population, especially in emerging markets where healthcare systems may not have sufficient funding to support widespread adoption. Additionally, reimbursement issues and the lack of uniform insurance coverage across different regions contribute to the financial burden on healthcare providers and patients. For instance, Medtronic announced in May 2024 that it would integrate artificial intelligence into its Reveal Linq ICM devices in the U.S., Australia, and New Zealand, with plans to introduce the AI update in Europe by the end of 2024. This demonstrates the financial and regulatory hurdles companies face when launching new technologies in the global market. As the demand for cardiovascular care grows, it becomes crucial to find cost-effective solutions to ensure that life-saving devices are accessible to a broader demographic, especially in developing regions. The challenge lies in balancing innovation and affordability while maintaining the quality and safety standards that cardiovascular devices require.

Technological Advancements and Innovation

Another lucrative opportunity in the cardiovascular devices market is the ongoing advancement of technology, particularly in the areas of wearable devices, AI-driven diagnostics, and minimally invasive surgical tools. Wearable health devices, such as ECG monitors and blood pressure sensors, are gaining popularity due to their convenience and ability to monitor cardiovascular health in real-time. Moreover, the integration of artificial intelligence (AI) in cardiovascular diagnostics and treatments is expected to enhance the accuracy of diagnosis and reduce complications. The development of next-generation devices, such as bioresorbable stents, robotic-assisted surgeries, and implantable smart devices, presents significant opportunities for companies to lead innovation in cardiovascular care. Manufacturers investing in R\&D to produce cutting-edge, patient-centric products stand to gain a competitive advantage in the rapidly evolving market.

Market Segmentation Analysis

By Product

The global cardiovascular devices market is primarily segmented into diagnostic & monitoring devices and surgical devices. Diagnostic & monitoring devices include equipment such as electrocardiograms (ECGs), echocardiographs, and heart rate monitors that are crucial for diagnosing and tracking cardiovascular conditions. These devices play a vital role in early detection and ongoing management of heart diseases. The increasing prevalence of heart diseases and the growing emphasis on preventive healthcare contribute to the steady demand for diagnostic devices. On the other hand, surgical devices, which include pacemakers, defibrillators, stents, and other implantable devices, are essential in treating and managing severe cardiovascular conditions. These devices are often used in invasive procedures and are critical in improving the quality of life for patients with advanced cardiovascular diseases. As surgical techniques continue to evolve and minimally invasive procedures gain popularity, the demand for these advanced surgical devices is expected to rise significantly, driving growth in this segment.

By End-User

The end-user segment of the cardiovascular devices market is diverse, encompassing hospitals & clinics, diagnostic laboratories, ambulatory surgical centers, and other healthcare facilities. Hospitals and clinics dominate the market, accounting for the largest share due to their high patient volumes and the necessity for comprehensive cardiovascular care. These institutions are equipped with advanced cardiovascular diagnostic and surgical devices for treating a wide range of heart conditions. Diagnostic laboratories are also a key segment, as they provide specialized diagnostic services, including blood tests, ECGs, and imaging studies, which are crucial for detecting cardiovascular diseases. The growth of outpatient care, including the rise of ambulatory surgical centers, is another trend driving market expansion. These centers specialize in providing specialized cardiovascular procedures on an outpatient basis, offering patients more convenience and lower costs compared to traditional hospital settings. The ‘others’ category includes home care services and long-term care facilities, which are increasingly adopting cardiovascular monitoring devices for chronic disease management, further expanding the market opportunities.

Segments

Based on Product

Diagnostic & Monitoring Devices
Surgical Devices

Based on End User

Hospitals & Clinics
Diagnostic Laboratories
Ambulatory Surgical Centers
Others

Based on Diagnostic & Monitoring Devices Type

ECG
Implantable Cardiac Monitors
Holter Monitors
Mobile Cardiac Telemetry
MRI
Others

Based on Surgical Devices Type

Cardiac Resynchronization Therapy (CRT)
Implantable Cardioverter Defibrillators (ICDs
Pacemakers
Coronary Stents
Catheters

Based on Region

North America
S.
Canada
Mexico
Europe
Germany
France
K.
Italy
Spain
Rest of Europe
Asia Pacific
China
Japan
India
South Korea
South-east Asia
Rest of Asia Pacific
Latin America
Brazil
Argentina
Rest of Latin America
Middle East & Africa
GCC Countries
South Africa
Rest of the Middle East and Africa

Regional Analysis

North America (40%)

North America holds the largest market share of the global cardiovascular devices market, accounting for approximately 40% of the total market revenue. The primary driver of this dominance is the high prevalence of cardiovascular diseases in the region, particularly in the United States, where lifestyle-related factors such as obesity, hypertension, and diabetes contribute significantly to heart conditions. Additionally, North America benefits from advanced healthcare infrastructure, high healthcare expenditure, and a well-established reimbursement system. Major players in the cardiovascular devices market are based in this region, further bolstering its position. The increasing demand for minimally invasive procedures and the adoption of innovative devices such as implantable cardiac devices and diagnostic monitoring equipment continue to propel market growth.

Europe (30%)

Europe is the second-largest market for cardiovascular devices, holding a market share of around 30%. The region’s strong healthcare systems, high levels of healthcare spending, and well-established regulatory frameworks support the widespread adoption of advanced cardiovascular devices. The aging population across European countries also drives the demand for cardiovascular devices, as older adults are more susceptible to heart diseases. Furthermore, Europe’s increasing focus on preventive healthcare and the growing emphasis on early detection and treatment of cardiovascular diseases contribute to the growth of the market. Countries such as Germany, France, and the UK represent key markets in Europe, with high adoption rates of innovative cardiovascular technologies.

Key players

Abbott
GE HealthCare
Edwards Lifesciences Corporation
L. Gore & Associates, Inc.
Siemens Healthcare GmbH
BIOTRONIK SE & Co. KG
Canon Medical Systems Asia Pte. Ltd.
Braun SE
LivaNova PLC
Cardinal Health
Medtronic
Boston Scientific Corporation
Koninklijke Philips N.V.
Johnson & Johnson Services, Inc.
Lepu Medical Technology (Beijing) Co., Ltd.

Competitive Analysis

The global cardiovascular devices market is highly competitive, with several prominent players dominating the industry. Medtronic, Boston Scientific, and Abbott are among the leading companies, known for their wide range of advanced devices, including pacemakers, stents, and diagnostic equipment. These companies have a strong presence in both developed and emerging markets, backed by robust R\&D capabilities and extensive product portfolios. Siemens Healthcare and GE HealthCare focus on cutting-edge diagnostic and imaging devices, providing solutions critical for cardiovascular disease detection. Edwards Lifesciences and BIOTRONIK specialize in heart valve technologies and implantable devices, catering to the growing demand for minimally invasive procedures. Regional players like Lepu Medical Technology have a growing presence in China and surrounding markets, contributing to market expansion. Competitive strategies focus on innovation, strategic mergers and acquisitions, and enhancing product offerings to meet the diverse needs of cardiovascular patients worldwide.

Recent Developments

In February 2025, Abbott issued a safety notification for certain Assurity and Endurity pacemakers due to potential epoxy mixing issues during manufacturing, which could lead to device malfunction.

In April 2025, GE HealthCare launched the Revolution™ Vibe CT system featuring Unlimited One-Beat Cardiac imaging and AI solutions, enhancing cardiac imaging capabilities.

In April 2025, Medtronic reported promising evidence for its Affera™ pulsed field ablation technologies in treating atrial fibrillation patients.

In May 2024, Siemens Healthineers announced new cardiology applications with artificial intelligence for the Acuson Sequoia ultrasound system, including a new 4D transesophageal (TEE) transducer for cardiology exams.

In February 2025, Philips developed a miniaturized intracardiac transducer, enabling higher-resolution views of cardiac structures and functions, benefiting structural heart disease and electrophysiology procedures.

In March 2025, Boston Scientific announced the acquisition of SoniVie Ltd. to expand its interventional cardiology therapies offerings with ultrasound-based renal denervation technology.

In June 2024, Biovac Institute entered a partnership with Sanofi to locally manufacture inactivated polio vaccines in Africa, aiming to serve the potential needs of over 40 African countries.

Market Concentration and Characteristics

The global cardiovascular devices market is characterized by moderate to high concentration, with a few dominant players leading the market, including Medtronic, Boston Scientific, Abbott, and Siemens Healthcare. These companies control a significant share of the market, owing to their extensive product portfolios, strong R&D capabilities, and established presence in both developed and emerging markets. However, the market also includes several mid-sized and regional players such as Edwards Lifesciences, BIOTRONIK, and Lepu Medical Technology, which focus on specialized products like heart valves, stents, and diagnostic tools. The market’s competitive landscape is driven by continuous innovation in product development, including minimally invasive devices, wearable health technologies, and AI-driven diagnostic solutions. With growing demand for advanced cardiovascular care, there is a trend towards increasing consolidation through mergers and acquisitions, enabling companies to expand their product offerings and reach a broader patient base. Despite the dominance of key players, the market remains dynamic, offering opportunities for new entrants and smaller companies to leverage specialized technologies and regional expertise.

Report Coverage

The research report offers an in-depth analysis based on Product, End User, Diagnostic & Monitoring Devices Type, Surgical Devices Type and Region. It details leading market players, providing an overview of their business, product offerings, investments, revenue streams, and key applications. Additionally, the report includes insights into the competitive environment, SWOT analysis, current market trends, as well as the primary drivers and constraints. Furthermore, it discusses various factors that have driven market expansion in recent years. The report also explores market dynamics, regulatory scenarios, and technological advancements that are shaping the industry. It assesses the impact of external factors and global economic changes on market growth. Lastly, it provides strategic recommendations for new entrants and established companies to navigate the complexities of the market.

Future Outlook

As patient preference shifts towards less invasive treatments, the demand for minimally invasive cardiovascular devices is expected to increase. This trend will drive innovations in stents, pacemakers, and diagnostic tools, reducing recovery times and improving patient outcomes.

The continued development of AI-powered diagnostic tools and wearable health devices will revolutionize early detection and real-time monitoring. These innovations will enable more accurate diagnostics and improve preventive care, especially in remote patient management

With increasing healthcare investments in emerging markets, the adoption of cardiovascular devices is expected to grow rapidly. Countries in Asia Pacific, Latin America, and Africa will witness enhanced access to cardiovascular care, driving market expansion.

The global market will see a rise in personalized cardiovascular treatments, with devices tailored to individual patient needs. Innovations in 3D printing and genetic testing will enable more customized solutions for cardiovascular conditions.

As the global population ages, particularly in developed countries, the prevalence of cardiovascular diseases will increase. This demographic shift will significantly expand the demand for cardiovascular devices such as pacemakers, defibrillators, and stents.

The increasing use of robotic-assisted surgeries for cardiovascular procedures will enhance precision and reduce human error. Robotics will play a critical role in the future of complex heart surgeries, improving recovery times and patient safety.

The emphasis on preventive care, including regular screenings and early diagnosis, will drive the demand for diagnostic devices. This focus will reduce the incidence of advanced cardiovascular diseases and enhance long-term heart health.

The development of artificial hearts and advanced heart failure management devices will continue to evolve. With improvements in biocompatibility and device performance, artificial hearts will offer new solutions for patients with end-stage heart failure.

Remote patient monitoring technologies will grow in importance, offering continuous heart health monitoring and early intervention. These technologies will support chronic disease management and reduce hospital readmissions, making cardiovascular care more accessible.

As regulatory bodies streamline approval processes for innovative cardiovascular devices, market entry will become faster and more efficient. This trend will encourage more startups and small companies to enter the market, introducing innovative products to meet growing healthcare needs.

CHAPTER NO. 1 : INTRODUCTION 27

1.1.1. Report Description 27

Purpose of the Report 27

USP & Key Product 28

1.1.2. Key Benefits for Stakeholders 28

1.1.3. Target Audience 28

1.1.4. Report Scope 29

1.1.5. Regional Scope 30

CHAPTER NO. 2 : EXECUTIVE SUMMARY 31

2.1. Cardiovascular Devices Market Snapshot 31

2.1.1. Global Cardiovascular Devices Market, 2018 – 2032 (USD Million) 32

CHAPTER NO. 3 : GEOPOLITICAL CRISIS IMPACT ANALYSIS 33

3.1. Russia-Ukraine and Israel-Palestine War Impacts 33

CHAPTER NO. 4 : CARDIOVASCULAR DEVICES MARKET – INDUSTRY ANALYSIS 34

4.1. Introduction 34

4.2. Market Drivers 35

4.2.1. Driving Factor 1 Analysis 35

4.2.2. Driving Factor 2 Analysis 36

4.3. Market Restraints 37

4.3.1. Restraining Factor Analysis 37

4.4. Market Opportunities 38

4.4.1. Market Opportunities Analysis 38

4.5. Porter’s Five Force analysis 39

4.6. Value Chain Analysis 40

4.7. Buying Criteria 41

CHAPTER NO. 5 : ANALYSIS COMPETITIVE LANDSCAPE 42

5.1. Company Market Share Analysis – 2023 42

5.1.1. Global Cardiovascular Devices Market: Company Market Share, by Revenue, 2023 42

5.1.2. Global Cardiovascular Devices Market: Top 6 Company Market Share, by Revenue, 2023 42

5.1.3. Global Cardiovascular Devices Market: Top 3 Company Market Share, by Revenue, 2023 43

5.2. Global Cardiovascular Devices Market Company Revenue Market Share, 2023 44

5.3. Company Assessment Metrics, 2023 45

5.3.1. Stars 45

5.3.2. Emerging Leaders 45

5.3.3. Pervasive Players 45

5.3.4. Participants 45

5.4. Start-ups /Code Assessment Metrics, 2023 45

5.4.1. Progressive Companies 45

5.4.2. Responsive Companies 45

5.4.3. Dynamic Companies 45

5.4.4. Starting Blocks 45

5.5. Strategic Developments 46

5.5.1. Acquisition & Mergers 46

New Product Launch 46

Regional Expansion 46

5.6. Key Players Product Matrix 47

CHAPTER NO. 6 : PESTEL & ADJACENT MARKET ANALYSIS 48

6.1. PESTEL 48

6.1.1. Political Factors 48

6.1.2. Economic Factors 48

6.1.3. Social Factors 48

6.1.4. Technological Factors 48

6.1.5. Environmental Factors 48

6.1.6. Legal Factors 48

6.2. Adjacent Market Analysis 48

CHAPTER NO. 7 : CARDIOVASCULAR DEVICES MARKET – BY PRODUCT SEGMENT ANALYSIS 49

7.1. Cardiovascular Devices Market Overview, by Product Segment 49

7.1.1. Cardiovascular Devices Market Revenue Share, By Product, 2023 & 2032 50

7.1.2. Cardiovascular Devices Market Attractiveness Analysis, By Product 51

7.1.3. Incremental Revenue Growth Opportunities, by Product, 2024 – 2032 51

7.1.4. Cardiovascular Devices Market Revenue, By Product, 2018, 2023, 2027 & 2032 52

7.2. Diagnostic & Monitoring Devices 53

7.2.1. Global Cardiovascular Devices Market Revenue, By Diagnostic & Monitoring Device Types, 2018 – 2023 (USD Million) 54

7.2.2. Global Cardiovascular Devices Market Revenue for Diagnostic & Monitoring Devices, By Region, 2018 – 2023 (USD Million) 55

7.2.3. Global Cardiovascular Devices Market Revenue for Diagnostic & Monitoring Devices, By Region, 2024 – 2032 (USD Million) 55

7.3. Surgical Devices 56

7.3.1. Global Cardiovascular Devices Market Revenue, By Surgical Devices Types, 2018 – 2023 (USD Million) 57

7.3.2. Global Cardiovascular Devices Market Revenue, By Surgical Devices Types, 2018 – 2023 (USD Million) 57

7.3.3. Global Cardiovascular Devices Market Revenue for Surgical Devices, By Region, 2018 – 2023 (USD Million) 58

7.3.4. Global Cardiovascular Devices Market Revenue for Surgical Devices, By Region, 2024 – 2032 (USD Million) 58

CHAPTER NO. 8 : CARDIOVASCULAR DEVICES MARKET – BY END USER SEGMENT ANALYSIS 59

8.1. Cardiovascular Devices Market Overview, by End User Segment 59

8.1.1. Cardiovascular Devices Market Revenue Share, By End User, 2023 & 2032 60

8.1.2. Cardiovascular Devices Market Attractiveness Analysis, By End User 61

8.1.3. Incremental Revenue Growth Opportunities, by End User, 2024 – 2032 61

8.1.4. Cardiovascular Devices Market Revenue, By End User, 2018, 2023, 2027 & 2032 62

8.2. Hospitals & Clinics 63

8.2.1. Global Cardiovascular Devices Market for Hospitals & Clinics Revenue, By Region, 2018 – 2023 (USD Million) 64

8.2.2. Global Cardiovascular Devices Market for Hospitals & Clinics Revenue, By Region, 2024 – 2032 (USD Million) 64

8.3. Diagnostic Laboratories 65

8.3.1. Global Cardiovascular Devices Market for Diagnostic Laboratories Revenue, By Region, 2018 – 2023 (USD Million) 66

8.3.2. Global Cardiovascular Devices Market for Diagnostic Laboratories Revenue, By Region, 2024 – 2032 (USD Million) 66

8.4. Ambulatory Surgical Centers 67

8.4.1. Global Cardiovascular Devices Market for Ambulatory Surgical Centers Revenue, By Region, 2018 – 2023 (USD Million) 68

8.4.2. Global Cardiovascular Devices Market for Ambulatory Surgical Centers Revenue, By Region, 2024 – 2032 (USD Million) 68

8.5. Others 69

8.5.1. Global Cardiovascular Devices Market for Others Revenue, By Region, 2018 – 2023 (USD Million) 70

8.5.2. Global Cardiovascular Devices Market for Others Revenue, By Region, 2024 – 2032 (USD Million) 70

CHAPTER NO. 9 : CARDIOVASCULAR DEVICES MARKET – REGIONAL ANALYSIS 71

9.1. Cardiovascular Devices Market Overview, by Regional Segments 71

9.2. Region 72

9.2.1. Global Cardiovascular Devices Market Revenue Share, By Region, 2023 & 2032 72

9.2.2. Cardiovascular Devices Market Attractiveness Analysis, By Region 73

9.2.3. Incremental Revenue Growth Opportunities, by Region, 2024 – 2032 73

9.2.4. Cardiovascular Devices Market Revenue, By Region, 2018, 2023, 2027 & 2032 74

9.2.5. Global Cardiovascular Devices Market Revenue, By Region, 2018 – 2023 (USD Million) 75

9.2.6. Global Cardiovascular Devices Market Revenue, By Region, 2024 – 2032 (USD Million) 75

9.3. Product 76

9.4. Global Cardiovascular Devices Market Revenue, By Product, 2018 – 2023 (USD Million) 76

9.5. Global Cardiovascular Devices Market Revenue, By Product, 2024 – 2032 (USD Million) 76

9.6. Diagnostic & Monitoring Device Types 77

9.6.1. Global Cardiovascular Devices Market Revenue, By Diagnostic & Monitoring Device Types, 2018 – 2023 (USD Million) 77

9.6.2. Global Cardiovascular Devices Market Revenue, By Diagnostic & Monitoring Device Types, 2018 – 2023 (USD Million) 77

9.7. Surgical Devices Types 78

9.7.1. Global Cardiovascular Devices Market Revenue, By Surgical Devices Types, 2018 – 2023 (USD Million) 78

9.7.2. Global Cardiovascular Devices Market Revenue, By Surgical Devices Types, 2018 – 2023 (USD Million) 78

9.8. End User 79

9.8.1. Global Cardiovascular Devices Market Revenue, By End User, 2018 – 2023 (USD Million) 79

9.8.2. Global Cardiovascular Devices Market Revenue, By End User, 2024 – 2032 (USD Million) 79

CHAPTER NO. 10 : CARDIOVASCULAR DEVICES MARKET – NORTH AMERICA 80

10.1. North America 80

10.1.1. Key Highlights 80

10.1.2. North America Cardiovascular Devices Market Revenue, By Country, 2018 – 2023 (USD Million) 81

10.2. Product 82

10.3. North America Cardiovascular Devices Market Revenue, By Product, 2018 – 2023 (USD Million) 82

10.4. Global Cardiovascular Devices Market Revenue, By Product, 2024 – 2032 (USD Million) 82

10.5. Diagnostic & Monitoring Device Types 83

10.5.1. North America Cardiovascular Devices Market Revenue, By Diagnostic & Monitoring Device Types, 2018 – 2023 (USD Million) 83

10.5.2. North America Cardiovascular Devices Market Revenue, By Diagnostic & Monitoring Device Types, 2018 – 2023 (USD Million) 83

10.6. Surgical Devices Types 84

10.6.1. North America Cardiovascular Devices Market Revenue, By Surgical Devices Types, 2018 – 2023 (USD Million) 84

10.6.2. North America Cardiovascular Devices Market Revenue, By Surgical Devices Types, 2018 – 2023 (USD Million) 84

10.7. End User 85

10.7.1. North America Cardiovascular Devices Market Revenue, By End User, 2018 – 2023 (USD Million) 85

10.7.2. North America Cardiovascular Devices Market Revenue, By End User, 2024 – 2032 (USD Million) 85

10.8. U.S. 86

10.9. Canada 86

10.10. Mexico 86

CHAPTER NO. 11 : CARDIOVASCULAR DEVICES MARKET – EUROPE 87

11.1. Europe 87

11.1.1. Key Highlights 87

11.1.2. Europe Cardiovascular Devices Market Revenue, By Country, 2018 – 2023 (USD Million) 88

11.2. Product 89

11.3. Europe Cardiovascular Devices Market Revenue, By Product, 2018 – 2023 (USD Million) 89

11.4. Europe Cardiovascular Devices Market Revenue, By Product, 2024 – 2032 (USD Million) 89

11.5. Diagnostic & Monitoring Device Types 90

11.5.1. Europe Cardiovascular Devices Market Revenue, By Diagnostic & Monitoring Device Types, 2018 – 2023 (USD Million) 90

11.5.2. Europe Cardiovascular Devices Market Revenue, By Diagnostic & Monitoring Device Types, 2018 – 2023 (USD Million) 90

11.6. Surgical Devices Types 91

11.6.1. Europe Cardiovascular Devices Market Revenue, By Surgical Devices Types, 2018 – 2023 (USD Million) 91

11.6.2. Europe Cardiovascular Devices Market Revenue, By Surgical Devices Types, 2018 – 2023 (USD Million) 91

11.7. End User 92

11.7.1. Europe Cardiovascular Devices Market Revenue, By End User, 2018 – 2023 (USD Million) 92

11.7.2. Europe Cardiovascular Devices Market Revenue, By End User, 2024 – 2032 (USD Million) 92

11.8. UK 93

11.9. France 93

11.10. Germany 93

11.11. Italy 93

11.12. Spain 93

11.13. Russia 93

11.14. Belgium 93

11.15. Netherland 93

11.16. Austria 93

11.17. Sweden 93

11.18. Poland 93

11.19. Denmark 93

11.20. Switzerland 93

11.21. Rest of Europe 93

CHAPTER NO. 12 : CARDIOVASCULAR DEVICES MARKET – ASIA PACIFIC 94

12.1. Asia Pacific 94

12.1.1. Key Highlights 94

12.1.2. Asia Pacific Cardiovascular Devices Market Revenue, By Country, 2018 – 2023 (USD Million) 95

12.2. Product 96

12.3. Asia Pacific Cardiovascular Devices Market Revenue, By Product, 2018 – 2023 (USD Million) 96

12.4. Asia Pacific Cardiovascular Devices Market Revenue, By Product, 2024 – 2032 (USD Million) 96

12.5. Diagnostic & Monitoring Device Types 97

12.5.1. Asia Pacific Cardiovascular Devices Market Revenue, By Diagnostic & Monitoring Device Types, 2018 – 2023 (USD Million) 97

12.5.2. Asia Pacific Cardiovascular Devices Market Revenue, By Diagnostic & Monitoring Device Types, 2018 – 2023 (USD Million) 97

12.6. Surgical Devices Types 98

12.6.1. Asia Pacific Cardiovascular Devices Market Revenue, By Surgical Devices Types, 2018 – 2023 (USD Million) 98

12.6.2. Asia Pacific Cardiovascular Devices Market Revenue, By Surgical Devices Types, 2018 – 2023 (USD Million) 98

12.7. End User 99

12.7.1. Asia Pacific Cardiovascular Devices Market Revenue, By End User, 2018 – 2023 (USD Million) 99

12.7.2. Asia Pacific Cardiovascular Devices Market Revenue, By End User, 2024 – 2032 (USD Million) 99

12.8. China 100

12.9. Japan 100

12.10. South Korea 100

12.11. India 100

12.12. Australia 100

12.13. Thailand 100

12.14. Indonesia 100

12.15. Vietnam 100

12.16. Malaysia 100

12.17. Philippines 100

12.18. Taiwan 100

12.19. Rest of Asia Pacific 100

CHAPTER NO. 13 : CARDIOVASCULAR DEVICES MARKET – LATIN AMERICA 101

13.1. Latin America 101

13.1.1. Key Highlights 101

13.1.2. Latin America Cardiovascular Devices Market Revenue, By Country, 2018 – 2023 (USD Million) 102

13.2. Product 103

13.3. Latin America Cardiovascular Devices Market Revenue, By Product, 2018 – 2023 (USD Million) 103

13.4. Latin America Cardiovascular Devices Market Revenue, By Product, 2024 – 2032 (USD Million) 103

13.5. Diagnostic & Monitoring Device Types 104

13.5.1. Latin America Cardiovascular Devices Market Revenue, By Diagnostic & Monitoring Device Types, 2018 – 2023 (USD Million) 104

13.5.2. Latin America Cardiovascular Devices Market Revenue, By Diagnostic & Monitoring Device Types, 2018 – 2023 (USD Million) 104

13.6. Surgical Devices Types 105

13.6.1. Latin America Cardiovascular Devices Market Revenue, By Surgical Devices Types, 2018 – 2023 (USD Million) 105

13.6.2. Latin America Cardiovascular Devices Market Revenue, By Surgical Devices Types, 2018 – 2023 (USD Million) 105

13.7. End User 106

13.7.1. Latin America Cardiovascular Devices Market Revenue, By End User, 2018 – 2023 (USD Million) 106

13.7.2. Latin America Cardiovascular Devices Market Revenue, By End User, 2024 – 2032 (USD Million) 106

13.8. Brazil 107

13.9. Argentina 107

13.10. Peru 107

13.11. Chile 107

13.12. Colombia 107

13.13. Rest of Latin America 107

CHAPTER NO. 14 : CARDIOVASCULAR DEVICES MARKET – MIDDLE EAST 108

14.1. Middle East 108

14.1.1. Key Highlights 108

14.1.2. Middle East Cardiovascular Devices Market Revenue, By Country, 2018 – 2023 (USD Million) 109

14.2. Product 110

14.3. Middle East Cardiovascular Devices Market Revenue, By Product, 2018 – 2023 (USD Million) 110

14.4. Middle East Cardiovascular Devices Market Revenue, By Product, 2024 – 2032 (USD Million) 110

14.5. Diagnostic & Monitoring Device Types 111

14.5.1. Middle East Cardiovascular Devices Market Revenue, By Diagnostic & Monitoring Device Types, 2018 – 2023 (USD Million) 111

14.5.2. Middle East Cardiovascular Devices Market Revenue, By Diagnostic & Monitoring Device Types, 2018 – 2023 (USD Million) 111

14.6. Surgical Devices Types 112

14.6.1. Middle East Cardiovascular Devices Market Revenue, By Surgical Devices Types, 2018 – 2023 (USD Million) 112

14.6.2. Middle East Cardiovascular Devices Market Revenue, By Surgical Devices Types, 2018 – 2023 (USD Million) 112

14.7. End User 113

14.7.1. Middle East Cardiovascular Devices Market Revenue, By End User, 2018 – 2023 (USD Million) 113

14.7.2. Middle East Cardiovascular Devices Market Revenue, By End User, 2024 – 2032 (USD Million) 113

14.8. UAE 114

14.9. KSA 114

14.10. Israel 114

14.11. Turkey 114

14.12. Iran 114

14.13. Rest of Middle East 114

CHAPTER NO. 15 : CARDIOVASCULAR DEVICES MARKET – AFRICA 115

15.1. Africa 115

15.1.1. Key Highlights 115

15.1.2. Africa Cardiovascular Devices Market Revenue, By Country, 2018 – 2023 (USD Million) 116

15.2. Product 117

15.3. Africa Cardiovascular Devices Market Revenue, By Product, 2018 – 2023 (USD Million) 117

15.4. Africa Cardiovascular Devices Market Revenue, By Product, 2024 – 2032 (USD Million) 117

15.5. Diagnostic & Monitoring Device Types 118

15.5.1. Africa Cardiovascular Devices Market Revenue, By Diagnostic & Monitoring Device Types, 2018 – 2023 (USD Million) 118

15.5.2. Africa Cardiovascular Devices Market Revenue, By Diagnostic & Monitoring Device Types, 2018 – 2023 (USD Million) 118

15.6. Surgical Devices Types 119

15.6.1. Africa Cardiovascular Devices Market Revenue, By Surgical Devices Types, 2018 – 2023 (USD Million) 119

15.6.2. Africa Cardiovascular Devices Market Revenue, By Surgical Devices Types, 2018 – 2023 (USD Million) 119

15.7. End User 120

15.7.1. Africa Cardiovascular Devices Market Revenue, By End User, 2018 – 2023 (USD Million) 120

15.7.2. Africa Cardiovascular Devices Market Revenue, By End User, 2024 – 2032 (USD Million) 120

15.8. Egypt 121

15.9. Nigeria 121

15.10. Algeria 121

15.11. Morocco 121

15.12. Rest of Africa 121

CHAPTER NO. 16 : COMPANY PROFILES 122

16.1. Abbott 122

16.1.1. Company Overview 122

16.1.2. Product Portfolio 122

16.1.3. Swot Analysis 122

16.1.4. Business Strategy 123

16.1.5. Financial Overview 123

16.2. GE HealthCare 124

16.3. Edwards Lifesciences Corporation 124

16.4. W. L. Gore & Associates, Inc. 124

16.5. Siemens Healthcare GmbH 124

16.6. BIOTRONIK SE & Co. KG 124

16.7. Canon Medical Systems Asia Pte. Ltd. 124

16.8. B. Braun SE 124

16.9. LivaNova PLC 124

16.10. Cardinal Health 124

16.11. Medtronic 124

16.12. Boston Scientific Corporation 124

16.13. Koninklijke Philips N.V., 124

16.14. Johnson & Johnson Services, Inc. 124

16.15. Lepu Medical Technology(Beijing)Co.,Ltd. 124

16.16. Others 124

]

List of Figures

FIG NO. 1. Global Cardiovascular Devices Market Revenue, 2018 – 2032 (USD Million) 32

FIG NO. 2. Porter’s Five Forces Analysis for Global Cardiovascular Devices Market 39

FIG NO. 3. Value Chain Analysis for Global Cardiovascular Devices Market 40

FIG NO. 4. Company Share Analysis, 2023 42

FIG NO. 5. Company Share Analysis, 2023 42

FIG NO. 6. Company Share Analysis, 2023 43

FIG NO. 7. Cardiovascular Devices Market – Company Revenue Market Share, 2023 44

FIG NO. 8. Cardiovascular Devices Market Revenue Share, By Product, 2023 & 2032 50

FIG NO. 9. Market Attractiveness Analysis, By Product 51

FIG NO. 10. Incremental Revenue Growth Opportunities by Product, 2024 – 2032 51

FIG NO. 11. Cardiovascular Devices Market Revenue, By Product, 2018, 2023, 2027 & 2032 52

FIG NO. 12. Global Cardiovascular Devices Market for Diagnostic & Monitoring Devices, Revenue (USD Million) 2018 – 2032 53

FIG NO. 13. Global Cardiovascular Devices Market for Surgical Devices, Revenue (USD Million) 2018 – 2032 56

FIG NO. 14. Cardiovascular Devices Market Revenue Share, By End User, 2023 & 2032 60

FIG NO. 15. Market Attractiveness Analysis, By End User 61

FIG NO. 16. Incremental Revenue Growth Opportunities by End User, 2024 – 2032 61

FIG NO. 17. Cardiovascular Devices Market Revenue, By End User, 2018, 2023, 2027 & 2032 62

FIG NO. 18. Global Cardiovascular Devices Market for Hospitals & Clinics, Revenue (USD Million) 2018 – 2032 63

FIG NO. 19. Global Cardiovascular Devices Market for Diagnostic Laboratories, Revenue (USD Million) 2018 – 2032 65

FIG NO. 20. Global Cardiovascular Devices Market for Ambulatory Surgical Centers, Revenue (USD Million) 2018 – 2032 67

FIG NO. 21. Global Cardiovascular Devices Market for Others, Revenue (USD Million) 2018 – 2032 69

FIG NO. 22. Global Cardiovascular Devices Market Revenue Share, By Region, 2023 & 2032 72

FIG NO. 23. Market Attractiveness Analysis, By Region 73

FIG NO. 24. Incremental Revenue Growth Opportunities by Region, 2024 – 2032 73

FIG NO. 25. Cardiovascular Devices Market Revenue, By Region, 2018, 2023, 2027 & 2032 74

FIG NO. 26. North America Cardiovascular Devices Market Revenue, 2018 – 2032 (USD Million) 80

FIG NO. 27. Europe Cardiovascular Devices Market Revenue, 2018 – 2032 (USD Million) 87

FIG NO. 28. Asia Pacific Cardiovascular Devices Market Revenue, 2018 – 2032 (USD Million) 94

FIG NO. 29. Latin America Cardiovascular Devices Market Revenue, 2018 – 2032 (USD Million) 101

FIG NO. 30. Middle East Cardiovascular Devices Market Revenue, 2018 – 2032 (USD Million) 108

FIG NO. 31. Africa Cardiovascular Devices Market Revenue, 2018 – 2032 (USD Million) 115

List of Tables

TABLE NO. 1. : Global Cardiovascular Devices Market: Snapshot 29

TABLE NO. 2. : Drivers for the Cardiovascular Devices Market: Impact Analysis 33

TABLE NO. 3. : Restraints for the Cardiovascular Devices Market: Impact Analysis 35

TABLE NO. 4. : Global Cardiovascular Devices Market Revenue, By Diagnostic & Monitoring Device Types, 2018 – 2023 (USD Million) 52

TABLE NO. 5. : Global Cardiovascular Devices Market Revenue, By Diagnostic & Monitoring Device Types, 2018 – 2023 (USD Million) 52

TABLE NO. 6. : Global Cardiovascular Devices Market Revenue for Diagnostic & Monitoring Devices, By Region, 2018 – 2023 (USD Million) 53

TABLE NO. 7. : Global Cardiovascular Devices Market Revenue for Diagnostic & Monitoring Devices, By Region, 2024 – 2032 (USD Million) 53

TABLE NO. 8. : Global Cardiovascular Devices Market Revenue, By Surgical Devices Types, 2018 – 2023 (USD Million) 55

TABLE NO. 9. : Global Cardiovascular Devices Market Revenue, By Surgical Devices Types, 2018 – 2023 (USD Million) 55

TABLE NO. 10. : Global Cardiovascular Devices Market Revenue for Surgical Devices, By Region, 2018 – 2023 (USD Million) 56

TABLE NO. 11. : Global Cardiovascular Devices Market Revenue for Surgical Devices, By Region, 2024 – 2032 (USD Million) 56

TABLE NO. 12. : Global Cardiovascular Devices Market for Hospitals & Clinics Revenue, By Region, 2018 – 2023 (USD Million) 62

TABLE NO. 13. : Global Cardiovascular Devices Market for Hospitals & Clinics Revenue, By Region, 2024 – 2032 (USD Million) 62

TABLE NO. 14. : Global Cardiovascular Devices Market for Diagnostic Laboratories Revenue, By Region, 2018 – 2023 (USD Million) 64

TABLE NO. 15. : Global Cardiovascular Devices Market for Diagnostic Laboratories Revenue, By Region, 2024 – 2032 (USD Million) 64

TABLE NO. 16. : Global Cardiovascular Devices Market for Ambulatory Surgical Centers Revenue, By Region, 2018 – 2023 (USD Million) 66

TABLE NO. 17. : Global Cardiovascular Devices Market for Ambulatory Surgical Centers Revenue, By Region, 2024 – 2032 (USD Million) 66

TABLE NO. 18. : Global Cardiovascular Devices Market for Others Revenue, By Region, 2018 – 2023 (USD Million) 68

TABLE NO. 19. : Global Cardiovascular Devices Market for Others Revenue, By Region, 2024 – 2032 (USD Million) 68

TABLE NO. 20. : Global Cardiovascular Devices Market Revenue, By Region, 2018 – 2023 (USD Million) 73

TABLE NO. 21. : Global Cardiovascular Devices Market Revenue, By Region, 2024 – 2032 (USD Million) 73

TABLE NO. 22. : Global Cardiovascular Devices Market Revenue, By Product, 2018 – 2023 (USD Million) 74

TABLE NO. 23. : Global Cardiovascular Devices Market Revenue, By Product, 2024 – 2032 (USD Million) 74

TABLE NO. 24. : Global Cardiovascular Devices Market Revenue, By Diagnostic & Monitoring Device Types, 2018 – 2023 (USD Million) 75

TABLE NO. 25. : Global Cardiovascular Devices Market Revenue, By Diagnostic & Monitoring Device Types, 2018 – 2023 (USD Million) 75

TABLE NO. 26. : Global Cardiovascular Devices Market Revenue, By Surgical Devices Types, 2018 – 2023 (USD Million) 76

TABLE NO. 27. : Global Cardiovascular Devices Market Revenue, By Surgical Devices Types, 2018 – 2023 (USD Million) 76

TABLE NO. 28. : Global Cardiovascular Devices Market Revenue, By End User, 2018 – 2023 (USD Million) 77

TABLE NO. 29. : Global Cardiovascular Devices Market Revenue, By End User, 2024 – 2032 (USD Million) 77

TABLE NO. 30. : North America Cardiovascular Devices Market Revenue, By Country, 2018 – 2023 (USD Million) 79

TABLE NO. 31. : North America Cardiovascular Devices Market Revenue, By Country, 2024 – 2032 (USD Million) 79

TABLE NO. 32. : North America Cardiovascular Devices Market Revenue, By Product, 2018 – 2023 (USD Million) 80

TABLE NO. 33. : Global Cardiovascular Devices Market Revenue, By Product, 2024 – 2032 (USD Million) 80

TABLE NO. 34. : North America Cardiovascular Devices Market Revenue, By Diagnostic & Monitoring Device Types, 2018 – 2023 (USD Million) 81

TABLE NO. 35. : North America Cardiovascular Devices Market Revenue, By Diagnostic & Monitoring Device Types, 2018 – 2023 (USD Million) 81

TABLE NO. 36. : North America Cardiovascular Devices Market Revenue, By Surgical Devices Types, 2018 – 2023 (USD Million) 82

TABLE NO. 37. : North America Cardiovascular Devices Market Revenue, By Surgical Devices Types, 2018 – 2023 (USD Million) 82

TABLE NO. 38. : North America Cardiovascular Devices Market Revenue, By End User, 2018 – 2023 (USD Million) 83

TABLE NO. 39. : North America Cardiovascular Devices Market Revenue, By End User, 2024 – 2032 (USD Million) 83

TABLE NO. 40. : Europe Cardiovascular Devices Market Revenue, By Country, 2018 – 2023 (USD Million) 86

TABLE NO. 41. : Europe Cardiovascular Devices Market Revenue, By Country, 2024 – 2032 (USD Million) 86

TABLE NO. 42. : Europe Cardiovascular Devices Market Revenue, By Product, 2018 – 2023 (USD Million) 87

TABLE NO. 43. : Europe Cardiovascular Devices Market Revenue, By Product, 2024 – 2032 (USD Million) 87

TABLE NO. 44. : Europe Cardiovascular Devices Market Revenue, By Diagnostic & Monitoring Device Types, 2018 – 2023 (USD Million) 88

TABLE NO. 45. : Europe Cardiovascular Devices Market Revenue, By Diagnostic & Monitoring Device Types, 2018 – 2023 (USD Million) 88

TABLE NO. 46. : Europe Cardiovascular Devices Market Revenue, By Surgical Devices Types, 2018 – 2023 (USD Million) 89

TABLE NO. 47. : Europe Cardiovascular Devices Market Revenue, By Surgical Devices Types, 2018 – 2023 (USD Million) 89

TABLE NO. 48. : Europe Cardiovascular Devices Market Revenue, By End User, 2018 – 2023 (USD Million) 90

TABLE NO. 49. : Europe Cardiovascular Devices Market Revenue, By End User, 2024 – 2032 (USD Million) 90

TABLE NO. 50. : Asia Pacific Cardiovascular Devices Market Revenue, By Country, 2018 – 2023 (USD Million) 93

TABLE NO. 51. : Asia Pacific Cardiovascular Devices Market Revenue, By Country, 2024 – 2032 (USD Million) 93

TABLE NO. 52. : Asia Pacific Cardiovascular Devices Market Revenue, By Product, 2018 – 2023 (USD Million) 94

TABLE NO. 53. : Asia Pacific Cardiovascular Devices Market Revenue, By Product, 2024 – 2032 (USD Million) 94

TABLE NO. 54. : Asia Pacific Cardiovascular Devices Market Revenue, By Diagnostic & Monitoring Device Types, 2018 – 2023 (USD Million) 95

TABLE NO. 55. : Asia Pacific Cardiovascular Devices Market Revenue, By Diagnostic & Monitoring Device Types, 2018 – 2023 (USD Million) 95

TABLE NO. 56. : Asia Pacific Cardiovascular Devices Market Revenue, By Surgical Devices Types, 2018 – 2023 (USD Million) 96

TABLE NO. 57. : Asia Pacific Cardiovascular Devices Market Revenue, By Surgical Devices Types, 2018 – 2023 (USD Million) 96

TABLE NO. 58. : Asia Pacific Cardiovascular Devices Market Revenue, By End User, 2018 – 2023 (USD Million) 97

TABLE NO. 59. : Asia Pacific Cardiovascular Devices Market Revenue, By End User, 2024 – 2032 (USD Million) 97

TABLE NO. 60. : Latin America Cardiovascular Devices Market Revenue, By Country, 2018 – 2023 (USD Million) 100

TABLE NO. 61. : Latin America Cardiovascular Devices Market Revenue, By Country, 2024 – 2032 (USD Million) 100

TABLE NO. 62. : Latin America Cardiovascular Devices Market Revenue, By Product, 2018 – 2023 (USD Million) 101

TABLE NO. 63. : Latin America Cardiovascular Devices Market Revenue, By Product, 2024 – 2032 (USD Million) 101

TABLE NO. 64. : Latin America Cardiovascular Devices Market Revenue, By Diagnostic & Monitoring Device Types, 2018 – 2023 (USD Million) 102

TABLE NO. 65. : Latin America Cardiovascular Devices Market Revenue, By Diagnostic & Monitoring Device Types, 2018 – 2023 (USD Million) 102

TABLE NO. 66. : Latin America Cardiovascular Devices Market Revenue, By Surgical Devices Types, 2018 – 2023 (USD Million) 103

TABLE NO. 67. : Latin America Cardiovascular Devices Market Revenue, By Surgical Devices Types, 2018 – 2023 (USD Million) 103

TABLE NO. 68. : Latin America Cardiovascular Devices Market Revenue, By End User, 2018 – 2023 (USD Million) 104

TABLE NO. 69. : Latin America Cardiovascular Devices Market Revenue, By End User, 2024 – 2032 (USD Million) 104

TABLE NO. 70. : Middle East Cardiovascular Devices Market Revenue, By Country, 2018 – 2023 (USD Million) 107

TABLE NO. 71. : Middle East Cardiovascular Devices Market Revenue, By Country, 2024 – 2032 (USD Million) 107

TABLE NO. 72. : Middle East Cardiovascular Devices Market Revenue, By Product, 2018 – 2023 (USD Million) 108

TABLE NO. 73. : Middle East Cardiovascular Devices Market Revenue, By Product, 2024 – 2032 (USD Million) 108

TABLE NO. 74. : Middle East Cardiovascular Devices Market Revenue, By Diagnostic & Monitoring Device Types, 2018 – 2023 (USD Million) 109

TABLE NO. 75. : Middle East Cardiovascular Devices Market Revenue, By Diagnostic & Monitoring Device Types, 2018 – 2023 (USD Million) 109

TABLE NO. 76. : Middle East Cardiovascular Devices Market Revenue, By Surgical Devices Types, 2018 – 2023 (USD Million) 110

TABLE NO. 77. : Middle East Cardiovascular Devices Market Revenue, By Surgical Devices Types, 2018 – 2023 (USD Million) 110

TABLE NO. 78. : Middle East Cardiovascular Devices Market Revenue, By End User, 2018 – 2023 (USD Million) 111

TABLE NO. 79. : Middle East Cardiovascular Devices Market Revenue, By End User, 2024 – 2032 (USD Million) 111

TABLE NO. 80. : Africa Cardiovascular Devices Market Revenue, By Country, 2018 – 2023 (USD Million) 114

TABLE NO. 81. : Africa Cardiovascular Devices Market Revenue, By Country, 2024 – 2032 (USD Million) 114

TABLE NO. 82. : Africa Cardiovascular Devices Market Revenue, By Product, 2018 – 2023 (USD Million) 115

TABLE NO. 83. : Africa Cardiovascular Devices Market Revenue, By Product, 2024 – 2032 (USD Million) 115

TABLE NO. 84. : Africa Cardiovascular Devices Market Revenue, By Diagnostic & Monitoring Device Types, 2018 – 2023 (USD Million) 116

TABLE NO. 85. : Africa Cardiovascular Devices Market Revenue, By Diagnostic & Monitoring Device Types, 2018 – 2023 (USD Million) 116

TABLE NO. 86. : Africa Cardiovascular Devices Market Revenue, By Surgical Devices Types, 2018 – 2023 (USD Million) 117

TABLE NO. 87. : Africa Cardiovascular Devices Market Revenue, By Surgical Devices Types, 2018 – 2023 (USD Million) 117

TABLE NO. 88. : Africa Cardiovascular Devices Market Revenue, By End User, 2018 – 2023 (USD Million) 118

TABLE NO. 89. : Africa Cardiovascular Devices Market Revenue, By End User, 2024 – 2032 (USD Million) 118

Frequently Asked Questions

What is the market size of the global cardiovascular devices market in 2023 and 2032?

The global cardiovascular devices market is projected to grow from USD 72,115.60 million in 2024 to USD 133,700.94 million by 2032, with a CAGR of 7.1% from 2025 to 2032.

What are the key drivers for the growth of the cardiovascular devices market?

The increasing prevalence of cardiovascular diseases, advancements in medical technology, and the rise in the aging population are key drivers fueling the market’s growth.

How is the Asia Pacific region contributing to the cardiovascular devices market?

The Asia Pacific region is expected to experience the highest growth rate, driven by increasing healthcare investments, improving medical infrastructure, and a rising patient population.

What are the technological advancements shaping the cardiovascular devices market?

Innovations such as next-generation stents, pacemakers, defibrillators, and wearable cardiovascular devices are shaping the future of the market, improving diagnosis and treatment options.

Purchase Options

Single User

$2699

Multi User

$3699

Custom Report

$5699

Let us help you

MIKE, North America

+1 304 308 1216

KEITH PHILLIPS, Europe

+44 7809 866 263

EMAIL US

Request Sample

Report delivery within 24 to 48 hours

– Other Info –

–What people say?-

I am very impressed with the information in this report. The author clearly did their research when they came up with this product and it has already given me a lot of ideas.

Jana Schmidt
CEDAR CX Technologies

– Connect with us –